ChromaDex Inc.
19Patents
18Active
19Granted
50Portfolio score
Filing activity: Mar 26, 2002 → Aug 24, 2023
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9975915B1 | Crystalline forms of nicotinoyl ribosides, modified derivatives thereof, and phosphorylated analogs thereof, and methods of preparation thereof | Chemistry; Metallurgy | 18 | Active |
| US10000520B2 | B-vitamin and amino acid conjugates ofnicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 6 | Active |
| US10183036B2 | Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors | Human Necessities | 4 | Active |
| US10934322B2 | B-vitamin and amino acid conjugates of nicotinoyl ribosides and reduced nicotinoyl ribosides, derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 4 | Active |
| US10689411B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 4 | Active |
| US11242364B1 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 3 | Active |
| US11274117B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 3 | Active |
| US10280190B2 | Nicotinic acid riboside or nicotinamide riboside compositions, reduced derivatives thereof, and the use thereof to enhance skin permeation in treating skin conditions | Human Necessities | 2 | Active |
| US6852342B2 | Compounds for altering food intake in humans | Human Necessities | 2 | Expired |
| US8841350B2 | Method for inducing UDP-glucuronosyltransferase activity using pterostilbene | Human Necessities | 2 | Active |
| US11345720B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US11214589B2 | Crystalline forms of nicotinoyl ribosides and derivatives thereof, and methods of preparation thereof | Chemistry; Metallurgy | 0 | Active |
| US11524022B2 | Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development | Human Necessities | 0 | Active |
| US10857172B2 | Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development | Human Necessities | 0 | Active |
| US12195494B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
| US11033568B2 | Nicotinamide riboside compositions for topical use in treating skin conditions | Human Necessities | 0 | Active |
| US10039725B2 | Method for treating non-melanoma skin cancer by inducing UDP-glucuronosyltransferase activity using pterostilbene | Human Necessities | 0 | Active |
| US10688118B2 | Nicotinamide riboside compositions for topical use in treating skin conditions | Human Necessities | 0 | Active |
| US11746123B2 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.